Core Points - Reddit is suing Anthropic for allegedly using its data to train AI models without a proper licensing agreement, claiming this use was unlawful and violated Reddit's user agreement [1][2] - This lawsuit marks Reddit as the first major tech company to legally challenge an AI model provider regarding its training data practices, joining other publishers in similar legal actions [2][3] Company Actions - Reddit has previously established agreements with AI model providers like OpenAI and Google, allowing them to train AI models on Reddit's data under specific terms that protect user interests and privacy [5] - Reddit's legal complaint states that Anthropic's scraper bots ignored the site's robots.txt files, which are intended to prevent automated systems from crawling websites [8] Legal Claims - Reddit is seeking compensatory damages and restitution for the enrichment Anthropic gained from scraping its content, along with an injunction to stop Anthropic from using Reddit's content [9] - Reddit's chief legal officer emphasized the company's stance against profit-seeking entities exploiting Reddit content without compensation or respect for user privacy [4][6]

Core Insights - Boeing has shown resilience in its commercial aerospace segment post-pandemic, but the 737 MAX program faces ongoing scrutiny and challenges that may hinder growth [1][9] Production and Regulatory Challenges - Following a door-plug detachment incident, the FAA has limited Boeing to 38 737 jets per month, a target only achieved in May 2025, with future production goals of 42 and 47 jets per month appearing overly optimistic due to labor shortages and supply constraints [2][4] - Spirit AeroSystems, Boeing's main supplier for 737 fuselages, is experiencing financial and operational difficulties, which could further delay production [3][9] - Increased FAA oversight and stringent inspections add complexity to Boeing's production ramp-up, creating uncertainty regarding regulatory clearance [4][9] Financial Performance - Boeing's 737 deliveries increased in Q1 2025, leading to a 56.7% revenue boost in its commercial unit, but concerns about the sustainability of this growth persist due to regulatory and supply chain risks [5][9] - Boeing's stock has risen 20.6% year-to-date, compared to a 25.5% increase in the aerospace-defense industry [8] Competitive Landscape - Supply chain issues are affecting the entire aerospace industry, including Boeing's competitor Airbus, which has had to reduce its production targets for 2024 [6] - Airbus has managed supply chain disruptions more effectively than Boeing, achieving higher aircraft deliveries in Q1 2025, with 136 commercial aircraft delivered compared to Boeing's 130 [7] Valuation and Estimates - Boeing is currently trading at a forward 12-month sales multiple of 1.80X, which is approximately 17.4% lower than the industry average of 2.18X [10] - The Zacks Consensus Estimate projects a year-over-year sales increase of 25.6% for 2025 and 16.2% for 2026, with EPS estimates trending higher over the past 60 days [11]

越来越多证据告诉我们，帕金森病这一全球增长最快的神经系统疾病或许能分成两种不同类型，一种生发自脑中，另一种源于身体而向脑进击。关于疾病 的全新认知能否带来我们亟需的新疗法？ 一、消失的心脏 丹麦奥胡斯大学的神经科学家佩尔·博格哈默（Per Borghammer）在大约二十年前有过一次"顿悟"，来自那时他研读的一篇论文。文章作者试图探究快速眼 动睡眠行为障碍（RBD）是否为帕金森病这一神经系统疾病的早期表现之一。 RBD是一种最常见的睡眠行为障碍，此病的症状为人在睡梦中通过肢体演绎梦境——后期发展出帕金森病的人群往往会在较早阶段经历RBD。 不过作者团队并未从大脑入手，而是选择寻找心脏部位的神经细胞损失。 历来被认为与大脑神经元退化相关的帕金森病实际上也影响心脏中那些控制心率、血压等自主神经功能的神经元。博格哈默表示："所有这些RBD患者的 心脏，似乎都完全'隐形'了，'消失'了。" 当然，这并非字面意义上的隐形和消失，只是他们体内负责产生去甲肾上腺素的神经元严重耗竭了，而去甲肾上腺素能调控心率，结果他们的心脏无法通 过放射性示踪剂扫描来显影。此类神经元损失本与帕金森病相关，但当时这些RBD人群均未确诊帕金森病 ...

Core Insights - Bioxytran, Inc. is advancing treatments for ischemic stroke and Alzheimer's disease through its universal oxygen carrier (UOC) technology, which is detailed in a newly published book by Prof. Avraham Mayevsky [1][2][3] - The UOC is designed to replace hyperbaric oxygen treatment (HBOT) by delivering therapeutic oxygen at the cellular level, providing a significant improvement over traditional methods [2] - The Mongolian gerbil model is utilized for research due to its unique brain structure that lacks compensatory mechanisms for blood flow, making it ideal for studying stroke pathophysiology [3][4] Company Overview - Bioxytran, Inc. focuses on developing complex carbohydrate-based therapeutics to meet critical medical needs across three core platforms: virology, cancer metastasis, and oxygen transport [5] - The company is also working on programs for pulmonary fibrosis and stroke treatment, with a specific product, BXT-25, showing potential to significantly reduce the time until treatment in emergency situations [5]

Core Insights - AbbVie has launched the second annual AbbVie Migraine Career Catalyst Award™ contest, providing financial support to individuals living with migraine to pursue their personal, professional, and educational goals [1][5][8] - The contest aims to raise awareness about the impact of migraine in the workplace, where it is often misunderstood, and to advocate for individuals affected by this condition [2][3][9] Group 1: Contest Details - The contest is open for entries until September 2, 2025, with 20 winners receiving $2,500 each [1][5][6] - Participants can submit essays, videos, or audio clips detailing their experiences with migraine and career aspirations [4][5] - Winners from the previous year utilized their awards for various professional development activities, such as creating migraine-friendly workspaces and enhancing their skills [3][4] Group 2: Impact of Migraine - Migraine is the second leading cause of disability globally, significantly affecting productivity and career growth [2][8] - Nearly 90% of individuals with migraine report that it interferes with their work performance, highlighting the need for support beyond medical treatment [2][8] - AbbVie is the only company with three approved migraine treatment products and is committed to addressing the challenges faced by individuals living with migraine in professional settings [9][10]

机器人与人类协作最为关键的问题在于如何突破物理约束，提升机器人系统的稳定性和安全性。近日苏黎世联邦理工 学院机器人系统实验室提出了一套CMDP全新框架，该框架通过约束强化学习在减少约束违反、提升系统鲁棒性方面 的明显优势，能够有效提升足式机器人在复杂环境中的运动性能。 | | Reward | Violations per episode | | --- | --- | --- | | PPO (unconstrained) | 24.96 (± 0.67) | 533.44 (± 108.94) | | P30 | 24.13 (± 1.55) | 0.96 (± 1.35) | | N-P30 | 24.13 (± 1.14) | 0.49 (± 0.88) | | PPO-Lagrangian | 23.68 (± 1.87) | 0.99 (± 1.31) | | N-IPO | 24.67 (± 0.84) | 1.33 (± 1.69) | | CRPO | 22.28 (± 1.70) | 0.96 (± 1.22) | | FOCOPS | 22.65 (± 3.02) | 15.82 (+ ...

your whole brain is looking for homeostasis. It doesn't really care about you always being happy or fulfilled or like overjoyed. If you're overjoyed, your brain's going to think, "Oh, there's a lot of these joy chemicals. Let's tune it down a little. We're going we don't need that many receptors because there's so much stuff flooding right now." And so, it's just like going to downregulate those receptors so that you get back to your baseline and your new overjoy state is now your baseline. So it means like ...

Core Insights - InStride has facilitated a partnership between Arizona State University (ASU) and Labcorp to launch a Master of Science in Cytology, addressing a critical shortage of cytotechnologists in the U.S. [1][2] - The program aims to provide accessible, high-quality training to meet the growing demand for cytotechnologists, with the first cohort starting in January 2025 [1][5]. Group 1: Partnership and Program Development - The collaboration was initiated at InStride's annual IMPACT summit, where leaders from ASU and Labcorp recognized the urgent need for trained cytotechnologists [3]. - The program was developed in just six months, showcasing the ability of universities to respond quickly to industry workforce needs [2][4]. Group 2: Educational Approach and Accessibility - The program combines ASU's online education expertise with hands-on clinical training, making cytology education available nationwide, unlike traditional programs concentrated in specific regions [5]. - Future expansions will allow enrollment beyond Labcorp employees and introduce undergraduate and certificate pathways in laboratory medicine [5]. Group 3: Industry Impact and Workforce Solutions - This partnership provides Labcorp with a scalable education solution to address workforce needs while offering clinical lab professionals a flexible pathway to advance their careers [6]. - Cytology is crucial for cancer screening and diagnosis, and the collaboration enables Labcorp employees to stay updated with advancements in diagnostic testing [7].

DETROIT — Jeep on Thursday revealed the first details and image of its new Cherokee SUV, which the company expects to assist in the brand's turnaround when it arrives later this year.The Stellantis brand said the new midsize SUV will feature a hybrid powertrain option but declined to specify if it would be a traditional hybrid or plug-in hybrid electric vehicle (PHEV), which the company currently offers on several SUVs."The all-new Jeep Cherokee headlines our efforts to deliver more product, innovation, cho ...

本文来自微信公众号：爱范儿 （ID：ifanr），作者：马扶搖，题图来自：AI生成 你或许不知道他的名字，但你一定接触过他的产品——《半衰期》《军团要塞》《反恐精英》甚至《DOTA 2》，他就是传奇游戏开发与发行商Valve公司 的联合创始人Gabe Newell，外号"G胖"。而目前全球规模最大的电子游戏数字分发平台Steam正是由Valve开发和经营的，每天都帮忙点亮全球几千万游戏 玩家的心中绮梦。 一提到Valve，绝对绕不开的话题就是《半衰期》（Half Life），这款被誉为"史上最伟大的游戏"的作品给整个游戏行业的剧情设计和环境交互领域做出了 不可估量的贡献，是一部毫无争议的传奇。而二十年后，《半衰期：爱莉克斯》又因为其在VR游戏的交互性、材质细节和关卡构建中的诸多革命性设 计，成为了VR游戏中"开宗立派"式的一款作品。 根据Gabe Newell自己的说法，《半衰期：爱莉克斯》是一项对于"长期技术的前瞻性投资"。不过虽然《爱莉克斯》是一款VR游戏，考虑到Valve公司以及 《半衰期》系列一直以来对于游戏交互技术的探索，Gabe所说的这个"长期技术"很有可能不只VR——而是一个更加宏大和重要的领域 ...